NCT06874855View on ClinicalTrials.gov

Lemborexant in Delayed Sleep Phase Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 13, 2023

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Delayed Sleep Phase Syndrome
Interventions
DRUG

Lemborexant

Lemborexant tablet administered orally once daily

DRUG

Placebo

Placebo to match Lemborexant tablet administered orally once daily

Trial Locations (1)

94107

RECRUITING

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

Eisai Co., Ltd.

INDUSTRY

collaborator

Stanford University

OTHER

lead

University of California, San Francisco

OTHER